CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: CC100;   Drug: Placebos
Sponsor:   Chemigen, LLC
Recruiting - verified February 2017
News Type: